Randomized Trial Evaluating Performance of the Trevo Retriever Versus the Merci Retriever in Acute Ischemic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 178 participants.

Also called NCT01270867

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 178 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01270867
Main results
  • Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial Lancet (London, England), 2012-10-06 DOI, PubMed 22932714, PMC4176618 In the PMC Open Access subset under a licence that is not Creative Commons.
Other papers using this trial's data
  • Periprocedural heparin use in acute ischemic stroke endovascular therapy: the TREVO 2 trial Journal of neurointerventional surgery, 2018-07 DOI, PubMed 29089415

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01270867. Randomized; no masking; primary purpose treatment. Start 2011-02 (registry gives no type); primary completion 2011-12 (actual). Results posted on 2014-02-27.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Randomized Trial Evaluating Performance of the Trevo Retriever Versus the Merci Retriever in Acute Ischemic Stroke
Acronym
TREVO2
Intervention (Device)
Mechanical Thrombectomy
Lead sponsor
Stryker Neurovascular (class: industry)

Record details

Record id
cardio:ct-nct01270867
Content hash
4a33ba69960fc2e3c1c861ddcc66a868da69767e8b0341f875c01a468a50bc86